Hot pre-market trades in US stocks: Fusemachines up 10.53% in pre-market; Lumentum up 4.61% in pre-market
I'm LongbridgeAI, I can summarize articles.Fusemachines pre-market up 10.53%; Lumentum pre-market up 4.61%; Rain Enhancement Tech Holdco pre-market up 94.94%; VistaGen Therapeutics pre-market up 55.10%; eLong Power pre-market up 53.86%
Pre-market Hot Trades in US Stocks
Fusemachines is up 10.53% in pre-market trading. Based on recent key news:
-
On August 4, despite the booming physical infrastructure, the pure gambling business faces headwinds. DraftKings saw a nearly 17% revenue growth in the first quarter and launched its own prediction market, but fierce competition has caused its stock price to drop over 30% year-to-date. Meanwhile, blank check companies like Fusion Acquisition Corp are quietly waiting on the exchange, as the market now demands tangible assets and real cash flow. This news did not directly affect Fusemachines but reflects the market's preference for physical assets.
-
No other significant news recently.
-
No other significant news recently. The market's preference for physical assets is evident.
Lumentum is up 4.61% in pre-market trading. Based on recent key news:
-
On August 4, Lumentum CEO Michael Hurlston warned at the RAISE summit that the shortage of indium phosphide will exceed the memory market crisis, leading to an expanded supply-demand gap in the optical communications industry. Lumentum operates five InP wafer fabs, but shipments are still over 30% below customer demand, and this gap has further widened compared to the previous quarter. Citigroup's research report indicates a global supply-demand gap of over 30% for high-speed optical chips, with capacity locked in until 2028. This news drove Lumentum's stock price up. Source: Golden Finance
-
On August 4, optical communication concept stocks rose overall, with companies like Lumentum seeing strong rebounds in stock prices. Companies such as Zhongji Xuchuang and Cambridge Technology led the gains, reflecting market optimism about the optical communication industry. Source: Zhitong Finance
-
On August 1, Lumentum announced the establishment of its fifth indium phosphide wafer fab, expected to begin mass production in 2028. Despite the expansion plans, upstream raw material supply remains constrained, affecting market expectations for Lumentum in the long term. Source: Golden Finance. The supply-demand gap in the optical communication industry is expanding, and risks need to be monitored.
Top Gainers in Pre-market US Stocks
Rain Enhancement Tech Holdco is up 94.94% in pre-market trading. Based on recent key news:
-
On August 4, SU Group Holdings Ltd announced it received a Nasdaq delisting notice, causing its stock price to drop 21.6% in pre-market trading. This news triggered panic among investors, leading to a significant decline in stock price.
-
On August 4, Clearpoint Neuro Inc reported second-quarter earnings that missed expectations and lowered its sales guidance for fiscal year 2026, causing its stock price to drop 14.5% in pre-market trading. Poor earnings performance and lowered future sales expectations undermined investor confidence, leading to a stock price decline.
-
On August 4, Powell Industries Inc reported quarterly earnings that fell short of expectations, causing its stock price to drop 13.4% in pre-market trading. The disappointing earnings raised doubts about the company's profitability, leading to a stock price decline Recent market fluctuations have been significant, and investors should exercise caution.
VistaGen Therapeutics pre-market rose 55.10%. Based on recent key news:
-
On August 4, SRX Global acquired a minority stake in VistaGen Therapeutics. This investment aims to support VistaGen's late-stage neuroscience pipeline, particularly its intranasal "pherine" product candidates. SRX Global believes that VistaGen's stock is undervalued and plans to work with management and the board to create value. This news significantly boosted VistaGen's stock price.
-
On August 4, SRX Global announced its latest investment initiative in North Palm Beach, Florida. SRX Global enhanced shareholder value through its AI-driven approach, acquiring shares in VistaGen Therapeutics. VistaGen focuses on neuroscience advancements through the nasal-brain neural circuit, committed to developing and commercializing a new category of intranasal products called "pherines." This strategic acquisition indicates SRX's ongoing commitment to growth and innovation in the healthcare sector, further driving up VistaGen's stock price.
-
On August 4, SRX Global's CEO Kent Cunningham and Head of Investor Relations Valter Pinto issued a statement emphasizing the strategic significance of this acquisition and future plans. This statement further bolstered market confidence in VistaGen, leading to continued stock price increases. The healthcare industry has performed strongly recently, with significant capital inflows.
eLong Power pre-market rose 53.86%. Based on recent key news:
-
On August 3, eLong Power announced a public offering at a price of $0.12 per unit, expecting total proceeds of approximately $1.38 million. Following this announcement, the stock price surged.
-
On August 4, eLong Power announced that its lithium-ion battery manufacturing business would conduct a registered public offering to raise approximately $1.38 million. This move further propelled the stock price upward.
-
On August 3, eLong Power stated that its public offering includes 11,466,700 units, each consisting of one share of Class A common stock and one common warrant, with the warrants immediately exercisable at a price of $0.12 per share. Following this announcement, the market reacted positively, and the stock price rose. The lithium-ion battery industry has performed strongly recently, with significant capital inflows
